Zinc Oxide Nanoparticle Inhibits Tumorigenesis of Renal Cell Carcinoma by Modulating Lipid Metabolism Targeting miR-454-3p to Repressing Metabolism Enzyme ACSL4

BACKGROUND: Renal cell carcinoma (RCC) affects the life quality of patients with advanced diseases despite good prognosis and exhibits abnormal lipid metabolism. Zinc oxide nanoparticles (ZONs) are metal oxide nanoparticles that are regarded as promising therapeutic candidate for multiple diseases....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xudong, Cao, Tingting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975638/
https://www.ncbi.nlm.nih.gov/pubmed/35368896
http://dx.doi.org/10.1155/2022/2883404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975638/
https://www.ncbi.nlm.nih.gov/pubmed/35368896
http://dx.doi.org/10.1155/2022/2883404

Ejemplares similares